3654 results for «600»
3654 results
Breaking the calcium ceiling in bifurcation stenoses with contemporary PCI
18 May 2023 – From EuroPCR 2023
Watch the case of a 73-year-old man, active smoker, with HTN, dyslipidaemia and a history of severe polyvascular disease, who presented with CCS III angina in the last two months, and find out in this session how he was treated LIVE.
Solving complex mitral disease with transcatheter solutions
16 May 2023 – From EuroPCR 2023
This session compiles several complex scenarios such as severe mitral regurgitation induced by commissural prolapse, mitral regurgitation in non-obstructive hypertrophic cardiomyopathy, or mitral valve-in-valve in local anaesthesia, and explains how to overcome them!
DCB, DES, BRS - One fits all or all fit together?
18 May 2023 – From EuroPCR 2023
Check out this session to learn more about polymer-free treatment options with DCB and DES, increasing DCB in the daily cathlab routine, and the possibility of including BRS in the daily PCI routine.
Pivotal momentum for tricuspid valve interventions (Episode 1: the right side)
18 May 2023 – From EuroPCR 2023
Based on an in-depth review of the data from TRILUMINATE pivotal, a randomized trial whose findings were recently published in the NEW ENGLAND JOURNAL of MEDICINE, this lecture explains how these results will impact clinical practice in the treatment of tricuspid regurgitation. Join the speakers and...
Complications in left main interventions
16 May 2023 – From EuroPCR 2023
How do you recognize the signs of complications during procedures and achieve optimal results? Dive into this collection of cases to see your peers skillfully meet the challenges, learning valuable lessons in the process.
Innovations in TMVR and Intrepid trial updates
18 May 2023 – From EuroPCR 2023
This session explores the innovations in Transcatheter Mitral Valve replacement, with a special focus on the updates from the INTREPID and APOLLO EU trial, as well as patient benefits through case studies.
CTO PCI in images and case examples: what is new in 2026?
07 Jul 2026
Register for free to this webinar on Monday 31 August at 6:00pm with K. Mashayekhi, M. Ayoub and C. Ungureanu and learn to review the recent evidence on expected outcomes after CTO PCI, and much more!
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
From PROTECT-AF to CHAMPION-AF: Where do we stand today?
01 Jul 2026
In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.
Author
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...
Author
Author
Author
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
